Amy C. Peterson
CIK 1682735 · EVP Prod Dev & Med Aff & CMO · last filed 2025-05-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$28.77M
Companies
3
Total Filings
23
Lifetime Open-Market Net
-$12.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXEL | EVP Prod Dev & Med Aff & CMO | 538,169 | $53.13 | $28.59M | -$3.31M | 6 | 2025-05-16 |
| CTMX | EVP, Chief Development Officer | 58,433 | $3.01 | $175.9K | -$19.0K | 9 | 2023-03-20 |
| BeOne Medicines Ltd. (BGNE) Delisted | CMO, Immuno-oncology | 2,776 | $184.71 | $512.8K | -$8.76M | 8 | 2018-12-19 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-08-24 | BeOne Medicines Ltd. (BGNE) Delisted | Tax (F) | −28,185 | -$151.8K | EDGAR |
| 2017-06-29 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-24 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.